Serum Ferritin and Prognosis of DKA
Recruiting now
Conditions studied: Diabetic Ketoacidosis
In brief
the aim of this study is to: evaluate the association between serum ferritin levels and the clinical presentation and short-term prognosis of patients with DKA. Specifically, the correlation between its level and the severity of DKA at presentation and determine its prognostic value in predicting short-term outcomes.
Key facts
- Study ID
- NCT06748365
- Run by
- Sohag University
- People needed
- 100
- Starts
- 2025-01-01
- Expected to finish
- 2026-02-01
- Last updated by the study team
- 2025-05-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients with DKA :
- Adult Aged 18 years old or older .
- Type 1 DM , type 2 DM
- Diagnosis of DKA based on the American Diabetes Association criteria: blood glucose >250 mg/dL, arterial pH <7.3, serum bicarbonate <18 mEq/L,
You may not qualify if…
- Patients age less than 18 years old
- Iron deficiency anemia and iron overload
- Chronic Inflammatory Diseases: Conditions such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease
- Acute and chronic infections, including bacterial, viral, and fungal infections
- Pt presented with other acute complication (MI,stroke)
- CKD patients
- Patients with chronic liver diseases
- Patients with malignancy
- Pregnant women.
Where it is running
- Sohag university Hospitals — Sohag, Sohag Governorate, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.